An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

Clinical trial NCT01613599 · COMPLETED

Trial details

NCT number: NCT01613599
Sponsor: Genentech, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Granulomatosis With Polyangiitis Microscopic Polyangiitis

Start date: 2012-06-20
Primary completion: 2015-07-13
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.